W. Ju

发表

Safety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single‐ and Multiple‐Dose Administration to Healthy Male and Female Adult Volunteers

S. Peltz, S. Paushkin, L. Miller, 2007, Journal of clinical pharmacology.

Single-Dose Pharmacokinetics of Indinavir and the Effect of Food

Eric Woolf, Andrew T. Sterrett, Michael Hesney, 1998, Antimicrobial Agents and Chemotherapy.

PTC124 targets genetic disorders caused by nonsense mutations

Meenal Patel, Feng He, Masataka Kawana, 2007, Nature.

A Phase I/II Study of the Protease Inhibitor Indinavir in Children With HIV Infection

S. Steinberg, R. Nelson, P. Deutsch, 1998, Pediatrics.

Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: study design and model-independent data analysis.

P. Rolan, E. Woolf, J. Stone, 1999, Journal of pharmaceutical sciences.

Following Single-and Multiple-Dose Administration to Healthy Male and Female Adult Safety , Tolerability , and Pharmacokinetics of PTC 124 , a Nonaminoglycoside Nonsense Mutation

S. Peltz, S. Paushkin, L. Miller, 2007 .

Single-Dose Pharmacokinetics of Indinavir and the Effect of Food

A. Sterrett, S. Waldman, P. Deutsch, 1998, Antimicrobial Agents and Chemotherapy.

Steady‐state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection

D. Haas, L. Clough, P. Spearman, 2000, Clinical pharmacology and therapeutics.

Efficacy and Safety of Rofecoxib in Patients with Chronic Low Back Pain: Results from Two 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Trials

C. Fisher, R. Sperling, D. Krupa, 2003, Spine.